arrow
V

Vanessa Tyrrell

UNSW Sydney
H指数:16
被引数:1,261

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical utility of real-time comprehensive molecular profiling in childhood brain tumors
2024-09-050
PRE
Precision-guided treatment in high-risk pediatric cancers
2024-06-067
OAAI
Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives
2023-09-199
OA
High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer

原发性肿瘤细胞的高通量药物筛选确定治疗高危癌症儿童的治疗策略

2023-07-3114
OAAI
Parents' expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trial
CANCER
IF5.1
2023-06-297
OAAI
Precision Medicine Is Changing the Roles of Healthcare Professionals, Scientists, and Research Staff: Learnings from a Childhood Cancer Precision Medicine Trial
2023-06-237
OA
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer

一种新的转录特征识别高危儿科癌症中的T细胞浸润

2023-04-033
OAAI
Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genes

H3K27me3缺失的组蛋白H3-wild型弥漫性中线胶质瘤是一个独特的实体,具有EGFR或ACVR1突变和同源框基因的差异甲基化

2023-03-077
OAAI
In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer

肿瘤细胞的体外和体内药物筛选确定高危儿童癌症的新疗法

2021-12-2019
OAAI
Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma
2021-09-018
OAAI
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer

全基因组,转录组和甲基化分析可增强高风险儿科癌症的可操作靶标发现

2020-10-05229
PREAI
Balancing Expectations with Actual Realities: Conversations with Clinicians and Scientists in the First Year of a High-Risk Childhood Cancer Precision Medicine Trial

平衡期望与现实: 在高风险儿童癌症精准医学试验的第一年与临床医生和科学家的对话

2020-02-1426
OAAI
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design
2019-11-01114
OAAI